Filter Results:
(16)
Show Results For
- All HBS Web (16)
- Faculty Publications (5)
Show Results For
- All HBS Web (16)
- Faculty Publications (5)
Page 1 of 16
Results
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and... View Details
Keywords: Cipla; Pharmaceuticals; Drug Quality; Generics; Quality; Standards; Information Technology; Cost; Organizational Culture; Business History; Pharmaceutical Industry; India
Zaman, Muhammad H., and Tarun Khanna. "The Cost and Evolution of Quality at Cipla Ltd, 1935–2016." Business History Review 95, no. 2 (Summer 2021): 249–274.
- June 2003 (Revised May 2006)
- Case
Cipla
By: Rohit Deshpande and Laura Winig
The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
- April 2011 (Revised April 2015)
- Case
Cipla 2011
By: Rohit Deshpande, Sandra J. Sucher and Laura Winig
Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape. View Details
Keywords: Leadership; Leading Change; Leadership Style; Management Teams; Governance Compliance; Corporate Strategy; Pharmaceutical Industry
Deshpande, Rohit, Sandra J. Sucher, and Laura Winig. "Cipla 2011." Harvard Business School Case 511-050, April 2011. (Revised April 2015.)
- February 2007
- Supplement
Patents & Patients, CIPLA - Video
By: Rohit Deshpande
Deshpande, Rohit. "Patents & Patients, CIPLA - Video." Harvard Business School Video Supplement 507-705, February 2007.
- Profile
Prineeta Kulkarni
an Indian pharma, Cipla, that was specifically "focused on access and affordability," says Prineeta. Through her work on the acquisitions team, Prineeta helped Cipla expand access to inexpensive HIV medicine to more countries in... View Details
- Web
Published Materials - Creating Emerging Markets
Education in Emerging Markets Since the 1960s By: Valeria Giacomin, Geoffrey Jones and Erica Salvaj 10 JUN 2021 Article Business History Review The Cost and Evolution of Quality at Cipla Ltd, 1935–2016 By: Muhammad H. Zaman and Tarun... View Details
- 01 Dec 2004
- News
Finding a Balance
pirate by global pharmas that consider Cipla’s products a direct rip-off of patented drugs. From 1999 through 2002, Cipla enjoyed an average annual growth rate of 30.3 percent from the sale of more than 400 drugs, including generic... View Details
- 15 Feb 2012
- Op-Ed
Occupy Wall Street Protestors Have a Point
unaffordable (which the pharmaceutical company Cipla did with HIV/AIDS drugs in Africa), and that brought housing to urban poor (one of building materials maker CEMEX's accomplishments in Mexico). Based on our research, we believe the... View Details
- 01 Mar 2012
- News
Capitalism’s New Agenda
hundreds of millions of rural poor into the market system (as China Mobile did by bringing mobile phone service to the Chinese countryside), that brought medicine where it had been unaffordable (which the Indian pharmaceutical firm Cipla... View Details
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
business has a role to play in addressing it." For example, in one video clip, Yusuf Hamied, chairman of Mumbai-based pharmaceutical company Cipla, comments, "I'm a firm believer that if you're in the health care business like Cipla is,... View Details
Keywords: by Julia Hanna
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
profitability. In Chapter 6 we describe the work of drug company Cipla in India and telephone company China Mobile working in rural western China to bring affordable drugs, and smart telephone connections, respectively, to hundreds of... View Details
Keywords: by Martha Lagace
- 21 Jun 2011
- First Look
First Look: June 21
ecosystem. Purchase this note:http://cb.hbsp.harvard.edu/cb/product/911066-PDF-ENG Cipla 2011 Rohit Deshpandé, Sandra J. Sucher, and Laura WinigHarvard Business School Case 511-050 Dr. Yusuf Hamied, head of the Indian pharma and generics... View Details
Keywords: Sean Silverthorne